Showing 591-600 of 2876 results for "".
- PCA SKIN Launches At-Home Triple Exfoliation Peel Padshttps://modernaesthetics.com/news/pca-skin-launches-at-home-triple-exfoliation-peel-pads/2487305/PCA SKIN has launched Triple Exfoliation Peel Pads, an at-home peel treatment designed to support smoother, brighter, healthier-looking skin between professional treatments, according to a company announcement. The Scottsdale, Arizona-based brand said the product builds on more than 35 yea
- Icon Skincare Launches Prestige Brand Focused on Simplicity, Confidence, and Ritualhttps://modernaesthetics.com/news/icon-skincare-launches-prestige-brand-focused-on-simplicity-confidence-and-ritual/2487304/Innovative Skincare, the company behind the global cosmeceutical brand iS Clinical, has announced the launch of Icon Skincare, a new prestige skincare line designed to simplify routines while emphasizing skin health, confidence, and daily ritual. Founded by Bryan Johns and Alec Call, Icon
- Case Series Evaluates Anatomy-Based Thread Lifting for Nasolabial Fold Rejuvenationhttps://modernaesthetics.com/news/case-series-evaluates-anatomy-based-thread-lifting-for-nasolabial-fold-rejuvenation/2487262/A personalized, anatomy-guided thread lifting strategy using multiple vector patterns demonstrated favorable aesthetic outcomes for nasolabial fold (NLF) correction in a small retrospective case series published in JPRAS Open. In the study, investigators evaluated 22 patients trea
- RADIESSE Study Links Calcium Hydroxylapatite to ECM Regenerationhttps://modernaesthetics.com/news/radiesse-study-links-calcium-hydroxylapatite-to-ecm-regeneration/2487241/Merz Aesthetics announced new data showing that RADIESSE may support regeneration of multiple extracellular matrix components, including collagen, elastin, decorin, and versican, in human skin.
- FDA Clears Caliway’s Phase 3 CBL-514 Trial for Abdominal Fat Reductionhttps://modernaesthetics.com/news/fda-clears-caliways-phase-3-cbl-514-trial-for-abdominal-fat-reduction/2487183/Caliway Biopharmaceuticals announced that the US Food and Drug Administration (FDA) cleared the Investigational New Drug application for CBL-0302, also known as SUPREME-02, its second global pivotal phase 3 study of CBL-514 for abdominal subcutaneous fat reduction.1 The IND pass
- SCALE 2026: Practical Strategies for Treating GLP-1 RA–Related Aesthetic Changeshttps://modernaesthetics.com/news/scale-2026-practical-strategies-for-treating-glp-1related-aesthetic-changes/2487146/At the 2026 Music City SCALE meeting, Terrence Keaney, MD, discussed how dermatologists can proactively address facial aging, skin laxity, hair loss, and muscle loss associated with GLP-1 receptor agonists (RA)–mediated weight reduction. During a presentation at the 2026 Music City SCALE meeting
- From SCALE 2026: Microneedling Treatment Reduces Periorbital Wrinkle Severityhttps://modernaesthetics.com/news/microneedling-treatment-reduces-periorbital-wrinkle-severity/2487121/A prospective clinical study presented at the 2026 Music City SCALE Annual Meeting demonstrated significant improvement in periorbital wrinkles following treatment with the SkinStylus SteriLock MicroSystem (Hydrafacial LLC). The study evaluated the safety and effic
- LaserAway Marks 20 Years with Continued National Expansionhttps://modernaesthetics.com/news/laseraway-marks-20-years-with-continued-national-expansion/2487069/LaserAway is celebrating its 20th anniversary alongside continued national expansion and recent recognition within the aesthetics industry. The company, which specializes in aesthetic dermatology services, announced that it now operates more than 215 clinics across the United States. The c
- ASLMS 2026: Lumenis Reports New Laser Findings in Scalp Treatment, Rhinophyma, Photodamaged Skinhttps://modernaesthetics.com/news/aslms-2026-lumenis-reports-new-laser-findings-in-scalp-treatment-rhinophyma-photodamaged-skin/2487036/Lumenis Be Ltd. presented new clinical data on several aesthetic devices at the 45th Annual American Society for Laser Medicine and Surgery Conference, held May 7-9, 2026, in Savannah, Georgia, according to a company announcement. The presentations included data on FoLix, a 1565-nm nonabla
- Rapalogix Health Launches Re-Q Pro-Longevity Serum with Focus on Cellular Skin Aginghttps://modernaesthetics.com/news/rapalogix-health-launches-re-q-pro-longevity-serum-with-focus-on-cellular-skin-aging/2487003/Rapalogix Health has introduced its new Re-Q Pro-Longevity Face Serum during a virtual launch event on Thursday, May 7, featuring co-Founder and board-certified dermatologist Doris Day, MD, and co-Founder and CEO Rahul Mehta. The webinar focused on the science behind the product and the company’s